Company | GLAXO | Symbol |
Company Name | Glaxosmithkline (Pak) Ltd. | Company Name |
Sector | Pharma and Bio Tech | Sector |
Avg EPS | Rs 7.68 | Average of past year end EPS's |
Sector Average | Rs 19.85 | Sector average of the above |
Avg EPS FV | Rs 80.87 | Fair Value (DCF) based on average of past year end EPS's |
EPS | Rs 4.72 | Last four quarters EPS |
Sector Average | Rs 31.22 | Sector average of the above |
EPS FV | Rs 49.68 | Fair Value (DCF) based on last four quarters EPS |
Current Price | Rs 82.07 | Last closing stock price |
Updated | May 2013 | Data Month/Year |
Div | Rs 4.00 | Total dividend paid during last four quarters |
Sector Average | Rs 12.89 | Sector average of the above |
Div FV | Rs 42.11 | Fair value (DD) based on total dividend paid during last four quarters |
Avg Div | Rs 5.70 | Average of yearly dividends paid (including currently paid ones) |
Sector Average | Rs 10.44 | Sector average of the above |
Avg Div FV | Rs 60.00 | Fair value (DD) based on Average of yearly dividends paid (including current) |
Avg | Rs 39.63 | Fair value (averaged of other fair values) |
Upside | -51.71% | Upside potential (in percentage) based on the above Average. |
Div Yield | 4.87% | Dividend yield |
Sector Average | 4.18% | Sector average of the above |
Book Value | Rs 38.29 | Book Value |
Sector Average | Rs 190.24 | Sector average of the above |
FV FCF/S | Rs -9.89 | Fair Value based on free cash flow per share |
Outstanding Shares | 289,515,706 | Number of Outstanding Shares |
Current Assets | Rs 9,174.00 | Currency in Millions of Pakistan Rupees |
Total Liabilities | Rs 4,432.00 | Currency in Millions of Pakistan Rupees |
NCAV/S | Rs 16.38 | Net Current Asset Value / Share |
Total Assets | Rs 15,517.00 | Currency in Millions of Pakistan Rupees |
Quarter | September 2012 | Data Quarter |
CfO | Rs 552.00 | CASH FROM OPERATIONS (Millions of Rs) |
FCF/S | Rs -0.94 | Free Cash Flow per Share |
FCF/S Sector Avg | 14.79 | Sector Average FCF/S |
P/E | 17.39 | Price over earnings ratio |
P/E Sector Avg | 9.51 | Sector Average P/E |
P/B | 2.14 | Price over book value ratio |
P/B Sector Avg | 2.12 | Sector Average P/B |
PR | 84.75 | Payout Ratio (in %) |
PR Sector Avg | 40.43 | Sector average Payout Ratio (in %) |
D/E Ratio | 39.98 | Debt / Equite ratio (%) |
Sector D/E Ratio | 85.79 | Sector Debt / Equity ratio (%) |
Price Performance | ||
Last Trade Date | 22/05/2013 | |
Last Trade Price | Rs 82.07 | |
3 Months Avg | Rs 77.05 | |
6 Months Avg | Rs 75.12 | |
9 Months Avg | Rs 73.40 | |
12 Months Avg | Rs 72.00 | |
Score | -16 | cumulative +ve's, -ve's from above all |
Thursday, May 23, 2013
GLAXO - Glaxosmithkline (Pak) Ltd. - Company Analysis -23/05/2013
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment